NCT00549341View on ClinicalTrials.gov

PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia

PHASE1CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 31, 2006

Primary Completion Date

September 30, 2008

Study Completion Date

March 31, 2009

Conditions
Spasmodic Torticollis
Interventions
DRUG

Mentor Purified Toxin, Botulinum Toxn Type A, Purified Neurotoxin

100U vials, doses ranged from 50U-200U, single injection.

OTHER

Physiologic saline

Single injection.

Trial Locations (1)

93111

Mentor Worldwide, LLC, Santa Barbara

All Listed Sponsors
lead

Mentor Worldwide, LLC

INDUSTRY

NCT00549341 - PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia | Biotech Hunter | Biotech Hunter